Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001599298-24-000141

Co-Chief Executive Officer acquired 44,052 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Zanganeh Mahkam · Co-Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-09-11 Grant or award : show line 1 in the form +44,052 $22.70 $999,980 24,967,852 I
Loading xslF345X05/wk-form4_1726270177.xml…